126 related articles for article (PubMed ID: 1955570)
1. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy.
Tsukada N; Matsuda M; Miyagi K; Yanagisawa N
J Neuroimmunol; 1991 Dec; 35(1-3):285-93. PubMed ID: 1955570
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets.
Wu XM; Osoegawa M; Yamasaki K; Kawano Y; Ochi H; Horiuchi I; Minohara M; Ohyagi Y; Yamada T; Kira JI
J Neurol Sci; 2000 Aug; 177(1):24-31. PubMed ID: 10967179
[TBL] [Abstract][Full Text] [Related]
3. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
Mukae H; Kohno S; Morikawa N; Kadota J; Matsukura S; Hara K
Microbiol Immunol; 1994; 38(1):55-62. PubMed ID: 8052162
[TBL] [Abstract][Full Text] [Related]
4. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis.
Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M
Digestion; 1994; 55(4):268-73. PubMed ID: 8063032
[TBL] [Abstract][Full Text] [Related]
5. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women.
Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N
Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630
[TBL] [Abstract][Full Text] [Related]
6. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
[TBL] [Abstract][Full Text] [Related]
7. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
[TBL] [Abstract][Full Text] [Related]
8. Remarkable increase in CD26-positive T cells in patients with human T lymphotropic virus type I (HTLV-I) associated myelopathy.
Shibayama K; Nakamura T; Kinoshita I; Ueki Y; Nakao H; Eguchi K; Tsujihata M; Nagataki S
Intern Med; 1992 Sep; 31(9):1081-3. PubMed ID: 1358283
[TBL] [Abstract][Full Text] [Related]
9. Serum soluble CD4 and CD8 levels in Kawasaki disease.
Furukawa S; Matsubara T; Tsuji K; Motohashi T; Okumura K; Yabuta K
Clin Exp Immunol; 1991 Oct; 86(1):134-9. PubMed ID: 1914226
[TBL] [Abstract][Full Text] [Related]
10. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD4 and CD8 in serum from patients with localized scleroderma.
Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K
Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.
Tokano Y; Obara T; Hashimoto H; Okumura K; Hirose S
Clin Rheumatol; 1993 Sep; 12(3):368-74. PubMed ID: 8258239
[TBL] [Abstract][Full Text] [Related]
16. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.
Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG
Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951
[TBL] [Abstract][Full Text] [Related]
17. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid.
Sugimoto M; Nakashima H; Matsumoto M; Uyama E; Ando M; Araki S
Am Rev Respir Dis; 1989 Jun; 139(6):1329-35. PubMed ID: 2786358
[TBL] [Abstract][Full Text] [Related]
19. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
20. Soluble interleukin-2 receptor, CD4 and CD8 levels in melanoma: a longitudinal study.
Fierro MT; Lisa F; Novelli M; Bertero M; Bernengo MG
Dermatology; 1992; 184(3):182-9. PubMed ID: 1392109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
